Breaking News Instant updates and real-time market news.

TNDM

TNDM

, MDT

Medtronic

$86.29

0.11 (0.13%)

19:00
06/21/18
06/21
19:00
06/21/18
19:00

On The Fly: After Hours Movers

HIGHER: Tandem Diabetes (TNDM) up 19.2% after FDA approval of insulin pump... Medtronic (MDT) up 0.9% after FDA approval of its MiniMed 670G system. DOWN AFTER EARNINGS: Red Hat (RHT) down 11.9%... VMWare (VMW) down 1.3%, Splunk (SPLK) down 1.1%, in sympathy with Red Hat... SMART Holdings (SGH) down 2.9%. ALSO LOWER: Container Store (TCS) down 3.1% after equity offering... Lam Research (LRCX) down 0.3% after recommending that shareholders reject TRC Capital offer.

TNDM

TNDM

MDT

Medtronic

$86.29

0.11 (0.13%)

RHT

Red Hat

$165.62

-3.64 (-2.15%)

VMW

VMware

$152.08

-0.07 (-0.05%)

SPLK

Splunk

$113.06

-2.8 (-2.42%)

SGH

Smart Global

$39.79

-0.72 (-1.78%)

TCS

Container Store

$8.73

0.08 (0.92%)

LRCX

Lam Research

$176.01

1.54 (0.88%)

  • 21

    Jun

  • 21

    Jun

  • 22

    Jun

  • 25

    Jun

  • 25

    Jun

  • 25

    Jun

  • 26

    Jun

  • 09

    Jul

  • 10

    Jul

  • 10

    Jul

  • 10

    Jul

  • 12

    Jul

  • 12

    Jul

  • 12

    Jul

  • 17

    Jul

TNDM TNDM

06/18/18
LSCM
06/18/18
INITIATION
Target $30
LSCM
Buy
Tandem Diabetes initiated with a Buy at Lake Street
Lake Street analyst Brooks O'Neil started Tandem Diabetes with a Buy rating and $30 price target. The company is "poised for rapid growth in the insulin pump market," O'Neil tells investors in a research note. He expects FDA approval of Tandem's newest insulin pump, integrated with Dexcom's G5 continuous glucose monitor.
06/18/18
OPCO
06/18/18
NO CHANGE
Target $24
OPCO
Outperform
Tandem Diabetes price target raised to $24 from $15 at Oppenheimer
Oppenheimer analyst Steven Lichtman raised his price target for Tandem Diabetes to $24 from $15 given catalysts ahead and as the stock continues trades at a discount to high-growth medtech peers. The analyst reiterates an Outperform rating on the shares.
05/21/18
OPCO
05/21/18
NO CHANGE
Target $15
OPCO
Outperform
Tandem Diabetes price target raised to $15 from $10 at Oppenheimer
Oppenheimer analyst Steven Lichtman raised his price target for Tandem Diabetes to $15 from $10 to include an international launch, which is expected to begin in 2H18. The analyst reiterates an Outperform rating on the shares.
05/14/18
PIPR
05/14/18
UPGRADE
Target $13
PIPR
Overweight
Tandem Diabetes upgraded to Overweight from Neutral at Piper Jaffray
Piper Jaffray analyst JP McKim upgraded Tandem Diabetes to Overweight from Neutral after being on the road with the company's management. In a research note to investors, McKim said he believes Tandem is about to enter a "Goldilocks Period" where they have a "superior" closed loop system for several years. Additionally, the analyst sees upside to pump shipment with further room for multiple expansions and believes this is "just the beginning" of share appreciation. McKim has a $13 price target on the shares.
MDT Medtronic
$86.29

0.11 (0.13%)

06/11/18
PIPR
06/11/18
NO CHANGE
Target $32.5
PIPR
Overweight
Piper doesn't see regulatory issues for possible Stryker, Boston Scientific deal
Piper Jaffray analyst Matt O'Brien believes regulatory constraints from Stryker's (SYK) potential acquisition of Boston Scientific (BSX) "should not be much of an issue" given the little overlap between the businesses. The deal structure would be the biggest issue facing Stryker as the company would likely have to lever up heavily to acquire Boston Scientific, O'Brien tells investors in a research note. The analyst believes a transaction could occur in the $52B-$54B range, assuming a typical medtech takeout premium of 20%-30%. Consequently, any transaction would either require a significant level of debt or dilution to Stryker shareholders, the analyst contends. He sees the potential deal as likely being dilutive until 2021. O'Brien has an Overweight rating on Boston Scientific with a $32.50 price target. The stock closed the trading day up 7% to $34.32 after the Wall Street Journal reported that Stryker approached the company regarding a takeover.
06/18/18
PIPR
06/18/18
NO CHANGE
Target $96
PIPR
Overweight
Piper continues to recommend Medtronic after management meeting
After meeting with management, Piper Jaffray analyst Matt O'Brien continues to recommend building positions in Medtronic (MDT). The analyst views management's 4% plus revenue outlook over the next several years as "readily achievable and likely conservative." Management noted that given the low penetration rates of surgery performed on robots, they did not see a reason to be aggressive on pricing of their system once they get it to market, O'Brien tells investors in a research note. He believes that is a positive comment for Intuitive Surgical (ISRG). The analyst keeps an Overweight rating on Medtronic with a $96 price target.
06/06/18
NEED
06/06/18
NO CHANGE
Target $103
NEED
Buy
Medtronic's financial targets 'achievable,' says Needham
Needham analyst Mike Matson raised his price target for Medtronic to $103 from $97 and reiterated a Buy rating following the company's investor day in New York City, which he says increased his confidence in the company's product portfolio and that its new financial targets, including organic revenue growth for FY18-FY22 of 4%+, adjusted EPS growth of 8%+ and operating margin expansion of 40-50bps per year, are "realistic" and "achievable."
06/06/18
WBLR
06/06/18
INITIATION
WBLR
Market Perform
Medtronic assumed with a Market Perform at William Blair
William Blair analyst Margaret Kaczor assumed coverage of Medtronic with a Market Perform rating. The analyst believes it will be difficult for the company to grow sales above 4% without the help of acquisitions.
RHT Red Hat
$165.62

-3.64 (-2.15%)

06/19/18
RAJA
06/19/18
DOWNGRADE
RAJA
Market Perform
Red Hat downgraded to Market Perform from Outperform at Raymond James
06/19/18
BMOC
06/19/18
NO CHANGE
Target $192
BMOC
Market Perform
Red Hat price target raised to $192 from $180 at BMO Capital
BMO Capital analyst Keith Bachman raised his price target on Red Hat to $192, saying the company's Enterprise Linux system growth rate of low-to-mid teens is sustainable for the next few years based on the favorable adoption trends in the server market. Bachman adds that the company can also continue to generate revenue in the public cloud but at a "substantially lower share levels". Longer term, the analyst expects billings growth to decelerate from 21% this year to 16%-17% in the coming years, while questions around Red Hat's billings growth keep the stock rangebound. Bachman keeps his Market Perform rating.
06/19/18
06/19/18
DOWNGRADE

Market Perform
Red Hat downgraded to Market Perform ahead of Q1 report at Raymond James
As previously reported, Raymond James downgraded Red Hat to Market Perform from Outperform. Analyst Michael Turits changed his view ahead of Red Hat's Q1 report on Thursday saying shares are at peak valuation and the company is facing a difficult NTM growth outlook. Turits' Q1 reseller checks were mostly strong, but confirm company warnings that legacy middleware is slowing and there were some indications of further competitive pricing pressure. The analyst also sees other headwinds from the shift in focus to mid-market, ongoing extensions of larger deals, and reduced foreign exchange revenue tailwinds.
06/19/18
06/19/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Mattel (MAT) downgraded to Neutral from Buy at UBS with analyst Arpine Kocharyan citing the stock's recent 35% appreciation with little change in fundamentals. 2. F5 Networks (FFIV) downgraded to Neutral from Buy at Citi with analyst Jim Suva saying with the stock up 38% year-to-date, the company's price-to-earnings valuation multiple has increased from 14.8 times at the start of the year to 17.8 times. 3. Dr Pepper Snapple (DPS) downgraded to Hold from Buy at Stifel with analyst Mark Swartzberg saying the more he learns about Keurig Green Mountain, the more he is convinced it has "limited capacity for operating income growth." 4. Red Hat (RHT) downgraded to Market Perform from Outperform at Raymond James with analyst Michael Turits saying shares are at peak valuation and the company is facing a difficult NTM growth outlook. 5. AT&T (T) downgraded to a Neutral after resuming coverage from Overweight at JPMorgan with analyst Philip Cusick saying he believes reversal of the Time Warner acquisition by the Department of Justice is "very unlikely" and would not be surprised to see AT&T shares "rebound fairly quickly after a period of deal-related flowback." This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
VMW VMware
$152.08

-0.07 (-0.05%)

06/01/18
MSCO
06/01/18
NO CHANGE
Target $150
MSCO
Overweight
VMware price target raised to $150 from $143 at Morgan Stanley
Morgan Stanley analyst Keith Weiss said VMware's acceleration in license billings growth in Q1 "clearly shows" the company's fundamental performance hasn't been impacted by Dell's strategic review, though he recognizes the Dell risk may remain an impediment to fundamentals being fully reflected in VMware shares. Weiss raised his price target on VMware shares to $150 following what he called the "solid start" to FY19, but noted that absent the Dell overhang he believes the stock could trade closer to $170 if it was assigned a multiple more in-line with the group average.
06/01/18
RBCM
06/01/18
NO CHANGE
Target $160
RBCM
Outperform
VMware price target raised to $160 from $150 at RBC Capital
RBC Capital analyst Matthew Hedberg raised his price target for VMware to $160 from $150 and maintained an Outperform rating on shares after the company delivered a "strong" start to the year, highlighted by license billings and license revenue, which both grew 21% year over year. In a research note to investors, Hedberg said he believes VMware is well positioned for growth in non-vSphere including NSX, vSAN, VxRail and End User Computing, which he says are all "moving the needle." He also sees the potential for $1B in revenue synergies through Dell, and that while some investors may shy away from VMware given the Dell ownership, he thinks that it "remains in Dell's best interest to let this disruptive and well positioned asset thrive."
06/01/18
FBCO
06/01/18
NO CHANGE
Target $160
FBCO
Outperform
VMware price target raised to $160 from $155 at Credit Suisse
Credit Suisse analyst Brad Zelnick raised his price target for VMware to $160 from $155 and reiterated an Outperform rating on the shares following the company's "exceptional" Q1 results. While the company did not provide an update on Dell's 13D filing, Zelnick said VMware remains one of the few software stocks trading at a deep discount to intrinsic value.
06/05/18
DBAB
06/05/18
NO CHANGE
Target $120
DBAB
Buy
Dell Technologies price target raised to $120 from $114 at Deutsche Bank
Deutsche Bank analyst Karl Keirstead raised his price target for Dell Technologies to $120 saying the company's yesterday posted "another solid print" that showed signs of improvement, not deterioration. The results "further undermine the lingering narrative that Dell is so troubled that it must find a way to access VMware's cash," Keirstead tells investors in a research note. He keeps a Buy rating on Dell Technologies.
SPLK Splunk
$113.06

-2.8 (-2.42%)

06/15/18
06/15/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Southwest (LUV) downgraded to Hold from Buy at Argus with analyst John Staszak saying that despite being well managed and financially strong, its focus on the domestic market will lead to slower relative growth based on better expected performance in the international space. 2. Motorcar Parts (MPAA) downgraded to Neutral from Buy at Roth Capital with analyst Matt Koranda saying he expects margin erosion to intensify in the coming quarters as better industry growth is awaited. 3. BHP Billiton (BHP) and Rio Tinto (RIO) were downgraded to Hold from Buy at Investec. 4. AEGON (AEG) downgraded to Underperform from Neutral at BofA/Merrill with analyst Michael van Wegen citing "relatively strong" stock performance. 5. Splunk (SPLK) downgraded to Sell from Neutral at Citi with analyst Walter Pritchard saying he sees "growth drivers plateauing" and "some warning signs in numbers." This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
06/15/18
SBSH
06/15/18
DOWNGRADE
SBSH
Sell
Splunk downgraded to Sell from Neutral at Citi
Citi analyst Walter Pritchard downgraded Splunk to Sell on signs the company's growth is plateauing.
06/15/18
SBSH
06/15/18
DOWNGRADE
Target $98
SBSH
Sell
Citi downgrades Splunk to Sell on 'plateauing' growth drivers
Citi analyst Walter Pritchard downgraded Splunk (SPLK) to Sell from Neutral with an unchanged price target of $98. The stock in premarket trading is down 4%, or $4.72, to $114.78. The analyst sees "growth drivers plateauing" and "some warning signs in numbers." Splunk is facing increasing competition, adoption challenges caused by a "persistently unconventional" pricing model and market share in security nearing levels where others have had challenge breaking through, Pritchard tells investors in a research note. Further, he believes the stock is "vulnerable" with a valuation in-line with high-growth software-as-a-service app players. The analyst recommends Salesforce (CRM) and Salesforce (NOW) or security peer Palo Alto Networks (PANW) over Splunk (SPLK).
05/25/18
WELS
05/25/18
NO CHANGE
Target $135
WELS
Outperform
Splunk price target raised to $135 from $120 at Wells Fargo
Wells Fargo analyst Philip Winslow raised his price target for Splunk to $135 saying the company reported solid Q1 results with revenue, operating margins, and earnings above consensus expectations. The analyst continues to believe that Splunk can sustain "robust" revenue and cash flow growth due to its "differentiated, disruptive technology and continued scale in its operating model." He keeps an Outperform rating on the shares.
SGH Smart Global
$39.79

-0.72 (-1.78%)

05/15/18
STFL
05/15/18
NO CHANGE
Target $101
STFL
Buy
NAND flash negativity creates buying opportunity in Micron, says Stifel
Stifel analyst Kevin Cassidy said DRAM prices are tracking above his previous estimates for the May-ending quarter, while the NAND flash market "is growing and far from collapsing, as the bear case has it." The NAND flash negativity is overdone, creating buying opportunities in Micron (MU), Smart Global (SGH) and Western Digital (WDC), according to Cassidy. He raised his price target on Micron shares to $101 from $95 while maintaining a Buy rating on the stock. The firm also has Buy ratings on Smart Global and Western Digital.
03/23/18
NEED
03/23/18
NO CHANGE
Target $75
NEED
Strong Buy
Smart Global price target raised to $75 from $46 at Needham
Needham analyst Rajvindra Gill raised his price target on Smart Global to $75 after the company's "significant" beat on earnings and raise on guidance amid continued "shine" in the company's Brazil business. Gill says Brazil market is benefiting from rising smartphone shipments and selling prices along with a positive regulation environment, noting that the regulatory scope of local data content could increase to 80% from 60%. The analyst keeps his Strong Buy rating on Smart Global.
03/23/18
STFL
03/23/18
NO CHANGE
Target $56
STFL
Buy
Smart Global price target raised to $56 from $47 at Stifel
Stifel analyst Kevin Cassidy raised his price target on Smart Global to $56 from $47 following the company's fourth consecutive beat and raise report since their IPO last year. In a research note to investors, Cassidy called Smart Global his "top long idea," adding that the combination of market tailwinds, including stable memory market prices and the expanding Brazilian economy, and management's strategy as continuing the growth in calendar 2018. Cassidy has a Buy rating on shares.
04/26/18
STFL
04/26/18
NO CHANGE
STFL
Signs points to continued strong demand for memory, says Stifel
Following the quarterly reports from SK Hynix and Samsung, Stifel analyst Kevin Cassidy said industry data points continue to suggest demand for memory remains strong, primarily from the data center. He also believes memory suppliers continue to act rationally in maintaining incremental supply growth. Cassidy added that his average selling price data in the May quarter to date is tracking ahead of his estimates for both Micron (MU) and SMART Global (SGH).
TCS Container Store
$8.73

0.08 (0.92%)

LRCX Lam Research
$176.01

1.54 (0.88%)

06/18/18
STFL
06/18/18
NO CHANGE
STFL
Applied Materials' recent weakness an attractive buying opportunity, says Stifel
Stifel analyst Patrick Ho made adjustments to his estimates for Applied Materials (AMAT) as he estimates that $250M of shipments/revenues from Samsung (SSNLF) may fall out of 2018 into 2019 due to a push out of memory investment. However, he notes that the revisions are "much more modest" than those the firm has made for Lam Research (LRCX), citing the belief that Applied is more broadly exposed to many other customers. He sees recent weakness in Applied shares as presenting a "very attractive" buying opportunity and Ho maintains a Buy rating and $75 price target on the shares.
06/13/18
EVER
06/13/18
NO CHANGE
EVER
Applied Materials selloff a buying opportunity, says Evercore ISI
Evercore ISI analyst CJ Muse said that while he does expect a near-term pause for Lam Research (LRCX) and thinks sentiment could be a headwind for the stock, he sees no risk to consensus estimates for peers including Applied Materials (AMAT), ASML (ASML) and KLA-Tencor (KLAC). In particular, he sees the selloff in Applied Materials as a "clear buying opportunity" and would be adding to positions today, Muse tells investors.
06/13/18
RBCM
06/13/18
DOWNGRADE
Target $210
RBCM
Sector Perform
Lam Research cut to Sector Perform at RBC Capital on reduced near term view
RBC Capital analyst Mitch Steves downgraded Lam Research to Sector Perform from Outperform and lowered his price target to $210 from $245, saying the next twelve month period will likely see a muted stock price movement. The analyst notes that after an increase in NAND WFE market from $6.8B in 2013 to $16B today, he would "not be surprised" to see a decrease in the industry's total capital spending, adding that estimate revisions for Lam Research will likely trend down. Longer term, Steves still expects total spending to ramp higher.
06/13/18
RBCM
06/13/18
DOWNGRADE
RBCM
Sector Perform
Lam Research downgraded to Sector Perform from Outperform at RBC Capital

TODAY'S FREE FLY STORIES

UAL

United Continental

$83.91

2.57 (3.16%)

15:34
10/16/18
10/16
15:34
10/16/18
15:34
Options
United Continental options imply 7.3% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

AGLE

Aeglea BioTherapeutics

$10.00

0.56 (5.93%)

15:33
10/16/18
10/16
15:33
10/16/18
15:33
Conference/Events
Aeglea BioTherapeutics to hold a conference call »

Management provides an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

GILT

Gilat Satellite

$8.28

0.005 (0.06%)

15:33
10/16/18
10/16
15:33
10/16/18
15:33
Hot Stocks
Hispamar and Gilat launch satellite-based broadband service in Brazil »

Hispamar, the Brazilian…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

TSLA

Tesla

$275.70

16.12 (6.21%)

15:30
10/16/18
10/16
15:30
10/16/18
15:30
Periodicals
Banks approaching Tesla with financing ideas ahead of debt payments, FBN says »

Bankers are reaching out…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

  • 13

    Nov

  • 13

    Dec

DLTR

Dollar Tree

$86.62

5.64 (6.96%)

15:27
10/16/18
10/16
15:27
10/16/18
15:27
Recommendations
Dollar Tree analyst commentary  »

Buckingham reiterates…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VZ

Verizon

$53.53

-0.07 (-0.13%)

, S

Sprint

$6.38

0.1 (1.59%)

15:25
10/16/18
10/16
15:25
10/16/18
15:25
Hot Stocks
FCC calls on wireless cos to waive bills of Floridians affected by hurricane »

Federal Communications…

VZ

Verizon

$53.53

-0.07 (-0.13%)

S

Sprint

$6.38

0.1 (1.59%)

TMUS

T-Mobile

$68.72

1.1 (1.63%)

USM

U.S. Cellular

$48.55

0.62 (1.29%)

T

AT&T

$32.39

0.03 (0.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

  • 24

    Oct

  • 02

    Nov

  • 06

    Nov

  • 12

    Nov

  • 13

    Nov

BLK

BlackRock

$404.72

-22.68 (-5.31%)

15:21
10/16/18
10/16
15:21
10/16/18
15:21
Recommendations
BlackRock analyst commentary  »

BlackRock weakness a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 17

    Oct

VRSK

Verisk Analytics

$115.81

2.5 (2.21%)

15:20
10/16/18
10/16
15:20
10/16/18
15:20
Hot Stocks
Geomni forms strategic alliance with Skyline Software Systems »

Geomni, a Verisk…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

OSTK

Overstock.com

$26.96

0.18 (0.67%)

15:19
10/16/18
10/16
15:19
10/16/18
15:19
Hot Stocks
Overstock announces completion of issuance of preferred tZERO security tokens »

tZERO, a portfolio…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CSX

CSX

$72.25

1.39 (1.96%)

15:19
10/16/18
10/16
15:19
10/16/18
15:19
Options
CSX options imply 8.5% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

FCB

FCB Financial

$43.96

-0.69 (-1.55%)

15:17
10/16/18
10/16
15:17
10/16/18
15:17
Hot Stocks
FCB does not see material adverse portfolio impact from Hurricane Michael »

FCB Financial reports it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

15:17
10/16/18
10/16
15:17
10/16/18
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

15:16
10/16/18
10/16
15:16
10/16/18
15:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

15:05
10/16/18
10/16
15:05
10/16/18
15:05
General news
Treasury Closing Summary: »

Treasury Closing Summary:…

MAXR

Maxar Technologies

$30.30

0.89 (3.03%)

15:04
10/16/18
10/16
15:04
10/16/18
15:04
Hot Stocks
Maxar's MDA ships final spacecraft in preparation for RADARSAT mission »

MDA, a Maxar Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IBM

IBM

$144.76

3.64 (2.58%)

15:04
10/16/18
10/16
15:04
10/16/18
15:04
Options
IBM options imply 7.1% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 21

    Oct

  • 22

    Oct

  • 03

    Mar

BA

Boeing

$367.17

8.36 (2.33%)

15:02
10/16/18
10/16
15:02
10/16/18
15:02
Hot Stocks
Boeing sees air cargo traffic doubling in 20 years »

Boeing projects air cargo…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 24

    Oct

CLDR

Cloudera

$15.68

0.44 (2.89%)

15:01
10/16/18
10/16
15:01
10/16/18
15:01
Hot Stocks
Cloudera announces strategic alliance with NEC »

Cloudera announced a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

MNKD

MannKind

$1.90

0.24 (14.46%)

15:00
10/16/18
10/16
15:00
10/16/18
15:00
Hot Stocks
FDA sends warning letter to MannKind over Affrezza marketing »

In a warning letter sent…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CCK

Crown Holdings

$47.93

1.44 (3.10%)

15:00
10/16/18
10/16
15:00
10/16/18
15:00
Options
Call spread in Crown Holdings in front of earnings »

Call spread in Crown…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

ONDK

On Deck Capital

$7.28

0.51 (7.53%)

, JPM

JPMorgan

$108.59

2.25 (2.12%)

14:55
10/16/18
10/16
14:55
10/16/18
14:55
Recommendations
On Deck Capital, JPMorgan analyst commentary  »

Janney Montgomery Scott…

ONDK

On Deck Capital

$7.28

0.51 (7.53%)

JPM

JPMorgan

$108.59

2.25 (2.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 21

    Oct

  • 24

    Oct

  • 06

    Nov

  • 06

    Nov

  • 26

    Feb

OSTK

Overstock.com

$27.11

0.33 (1.23%)

14:50
10/16/18
10/16
14:50
10/16/18
14:50
Hot Stocks
Overstock.com says Customer Day 'strongest' non-Holiday sale in company history »

Overstock.com reported…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DWDP

DowDuPont

$60.29

1.36 (2.31%)

14:50
10/16/18
10/16
14:50
10/16/18
14:50
Options
DowDuPont draws call buyers »

DowDuPont draws call…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NFLX

Netflix

$341.60

8.49 (2.55%)

14:49
10/16/18
10/16
14:49
10/16/18
14:49
Options
Netflix options imply 14.9% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 13

    Nov

14:45
10/16/18
10/16
14:45
10/16/18
14:45
General news
Canada Manufacturing Preview »

Canada Manufacturing…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.